Cargando…
Dihydropyrimidinase-related protein 5 controls glioblastoma stem cell characteristics as a biomarker of proneural-subtype glioblastoma stem cells
Glioblastoma (GBM) is the most aggressive and malignant brain tumor, resulting in a poor prognosis. The current therapy for GBM consists in concurrent radiation and chemotherapy following removal of the tumor. Although the therapy prolongs patient survival, recurrence often occurs. The major cause o...
Autores principales: | Park, Min Gi, Seo, Sunyoung, Ham, Seok Won, Choi, Sang-Hun, Kim, Hyunggee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7377049/ https://www.ncbi.nlm.nih.gov/pubmed/32724355 http://dx.doi.org/10.3892/ol.2020.11668 |
Ejemplares similares
-
Higher vascularity at infiltrated peripheral edema differentiates proneural glioblastoma subtype
por: Chelebian, Eduard, et al.
Publicado: (2020) -
Altered cytoskeletal status in the transition from proneural to mesenchymal glioblastoma subtypes
por: Keller, Maureen, et al.
Publicado: (2022) -
PATZ1 is a new prognostic marker of glioblastoma associated with the stem-like phenotype and enriched in the proneural subtype
por: Guadagno, Elia, et al.
Publicado: (2017) -
Angiogenin Upregulation Independently Predicts Unfavorable Overall Survival in Proneural Subtype of Glioblastoma
por: Hu, Ji-liang, et al.
Publicado: (2019) -
CDK4/6 inhibition is more active against the glioblastoma proneural subtype
por: Li, Ming, et al.
Publicado: (2017)